Literature DB >> 19235264

Spatiotemporal tracking of cells in tissue-engineered cardiac organoids.

Rohin K Iyer1, Jane Chui, Milica Radisic.   

Abstract

Cardiac tissue engineering aims to create myocardial patches for repair of defective or damaged native heart muscle. The inclusion of non-myocytes in engineered cardiac tissues has been shown to improve the properties of cardiac tissue compared to tissues engineered from enriched populations of myocytes alone. While attempts have been made to mix non-myocytes (fibroblasts, endothelial cells) with cardiomyocytes, very little is understood about how the tissue properties are affected by varying the respective ratios of the three cell types and how these cells assemble into functional tissues with time. The goal of this study was to investigate the effects of modulating the ratios of the three cell types and to spatially and temporally track cardiac tri-cultures of cells. Primary neonatal cardiac fibroblasts and D4T endothelial cells were incubated in 5 microM CellTracker green dye and CellTracker red dye, respectively, while neonatal cardiomyocytes were labelled with 20 microg/mL DAPI. The non-myocytes were seeded either sequentially (pre-culture) or simultaneously (tri-culture) in Matrigel-coated microchannels and allowed to form organoids, as in our previous studies. We also varied the seeding percentage of cardiomyocytes while keeping the total cell number constant in an attempt to improve the functional properties of the organoids. Organoids were imaged on days 1 and 4. Endothelial cells were seen to aggregate into clusters when simultaneously tri-cultured with myocytes and fibroblasts, while pre-cultures contained elongated cells. Functional properties of organoids were improved by increasing the seeding percentage of enriched cardiomyocytes from 40% to 80%.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19235264      PMCID: PMC2768035          DOI: 10.1002/term.153

Source DB:  PubMed          Journal:  J Tissue Eng Regen Med        ISSN: 1932-6254            Impact factor:   3.963


  20 in total

1.  Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies.

Authors:  N Bursac; M Papadaki; R J Cohen; F J Schoen; S R Eisenberg; R Carrier; G Vunjak-Novakovic; L E Freed
Journal:  Am J Physiol       Date:  1999-08

2.  Fluorescent cell labeling for in vivo and in vitro cell tracking.

Authors:  P K Horan; M J Melnicoff; B D Jensen; S E Slezak
Journal:  Methods Cell Biol       Date:  1990       Impact factor: 1.441

3.  Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds.

Authors:  Milica Radisic; Hyoungshin Park; Helen Shing; Thomas Consi; Frederick J Schoen; Robert Langer; Lisa E Freed; Gordana Vunjak-Novakovic
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-16       Impact factor: 11.205

4.  Engineering vascularized skeletal muscle tissue.

Authors:  Shulamit Levenberg; Jeroen Rouwkema; Mara Macdonald; Evan S Garfein; Daniel S Kohane; Diane C Darland; Robert Marini; Clemens A van Blitterswijk; Richard C Mulligan; Patricia A D'Amore; Robert Langer
Journal:  Nat Biotechnol       Date:  2005-06-19       Impact factor: 54.908

Review 5.  DAPI: a DNA-specific fluorescent probe.

Authors:  J Kapuscinski
Journal:  Biotech Histochem       Date:  1995-09       Impact factor: 1.718

6.  Carboxyfluorescein diacetate succinimidyl ester fluorescent dye for cell labeling.

Authors:  Xiao-Qi Wang; Xiu-Mei Duan; Li-Hua Liu; Yan-Qiu Fang; Yan Tan
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2005-06       Impact factor: 3.848

7.  A common precursor for hematopoietic and endothelial cells.

Authors:  K Choi; M Kennedy; A Kazarov; J C Papadimitriou; G Keller
Journal:  Development       Date:  1998-02       Impact factor: 6.868

8.  Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts.

Authors:  Wolfram-Hubertus Zimmermann; Ivan Melnychenko; Gerald Wasmeier; Michael Didié; Hiroshi Naito; Uwe Nixdorff; Andreas Hess; Lubos Budinsky; Kay Brune; Bjela Michaelis; Stefan Dhein; Alexander Schwoerer; Heimo Ehmke; Thomas Eschenhagen
Journal:  Nat Med       Date:  2006-04-02       Impact factor: 53.440

9.  Microfabricated poly(ethylene glycol) templates enable rapid screening of triculture conditions for cardiac tissue engineering.

Authors:  Rohin K Iyer; Loraine L Y Chiu; Milica Radisic
Journal:  J Biomed Mater Res A       Date:  2009-06       Impact factor: 4.396

10.  Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis.

Authors:  G Seghezzi; S Patel; C J Ren; A Gualandris; G Pintucci; E S Robbins; R L Shapiro; A C Galloway; D B Rifkin; P Mignatti
Journal:  J Cell Biol       Date:  1998-06-29       Impact factor: 10.539

View more
  13 in total

1.  A modular approach to cardiac tissue engineering.

Authors:  Brendan M Leung; Michael V Sefton
Journal:  Tissue Eng Part A       Date:  2010-10       Impact factor: 3.845

Review 2.  Engineered heart tissues and induced pluripotent stem cells: Macro- and microstructures for disease modeling, drug screening, and translational studies.

Authors:  Evangeline Tzatzalos; Oscar J Abilez; Praveen Shukla; Joseph C Wu
Journal:  Adv Drug Deliv Rev       Date:  2015-09-30       Impact factor: 15.470

Review 3.  Engineered circulatory scaffolds for building cardiac tissue.

Authors:  Shixing Huang; Yang Yang; Qi Yang; Qiang Zhao; Xiaofeng Ye
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

Review 4.  Establishing Early Functional Perfusion and Structure in Tissue Engineered Cardiac Constructs.

Authors:  Bo Wang; Sourav S Patnaik; Bryn Brazile; J Ryan Butler; Andrew Claude; Ge Zhang; Jianjun Guan; Yi Hong; Jun Liao
Journal:  Crit Rev Biomed Eng       Date:  2015

Review 5.  Engineered cardiac tissues.

Authors:  Rohin K Iyer; Loraine L Y Chiu; Lewis A Reis; Milica Radisic
Journal:  Curr Opin Biotechnol       Date:  2011-04-27       Impact factor: 9.740

6.  Bioacoustic-enabled patterning of human iPSC-derived cardiomyocytes into 3D cardiac tissue.

Authors:  Vahid Serpooshan; Pu Chen; Haodi Wu; Soah Lee; Arun Sharma; Daniel A Hu; Sneha Venkatraman; Adarsh Venkataraman Ganesan; Osman Berk Usta; Martin Yarmush; Fan Yang; Joseph C Wu; Utkan Demirci; Sean M Wu
Journal:  Biomaterials       Date:  2017-03-28       Impact factor: 12.479

7.  Vascular endothelial growth factor secretion by nonmyocytes modulates Connexin-43 levels in cardiac organoids.

Authors:  Rohin K Iyer; Devang Odedra; Loraine L Y Chiu; Gordana Vunjak-Novakovic; Milica Radisic
Journal:  Tissue Eng Part A       Date:  2012-08-06       Impact factor: 3.845

8.  Tissue engineering toward organ-specific regeneration and disease modeling.

Authors:  Christian Mandrycky; Kiet Phong; Ying Zheng
Journal:  MRS Commun       Date:  2017-07-31       Impact factor: 2.566

9.  Biofabrication enables efficient interrogation and optimization of sequential culture of endothelial cells, fibroblasts and cardiomyocytes for formation of vascular cords in cardiac tissue engineering.

Authors:  Rohin K Iyer; Loraine L Y Chiu; Gordana Vunjak-Novakovic; Milica Radisic
Journal:  Biofabrication       Date:  2012-07-31       Impact factor: 9.954

Review 10.  Engineering the Cellular Microenvironment of Post-infarct Myocardium on a Chip.

Authors:  Natalie N Khalil; Megan L McCain
Journal:  Front Cardiovasc Med       Date:  2021-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.